Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shore

Showing results (551-560 of 591) with videos related to

Pageof 60
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 24, 2020
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysisLaurence Klotz, Giovanni Lughezzani, Davide Maffei, et al.
The Prostate|November 20, 2019
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 studyDaniel P Petrylak, Nicholas J Vogelzang, Kamal Chatta, et al.
The Journal of Urology|June 10, 2026
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and ToxicityArvin George, Eric Giesler, Brian Mazzarella, et al.
Future Oncology (London, England)|November 11, 2025
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, et al.
Urologic Oncology|January 16, 2025
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancerSiamak Daneshmand, Ashish M Kamat, Neal D Shore, et al.
Urologic Oncology|September 21, 2023
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancerNeal D Shore, Dmitry M Polikarpov, Christopher M Pieczonka, et al.
Prostate Cancer and Prostatic Diseases|September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patientsNeal D Shore, Christopher M Pieczonka, Sean Heron, et al.
Urology Practice|August 4, 2023
Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. StudyClaus G Roehrborn, Steven N Gange, Neal D Shore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamideD E Rathkopf, M R Smith, C J Ryan, et al.
Cancer|September 5, 2019
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancerCelestia S Higano, Andrew J Armstrong, A Oliver Sartor, et al.
Pageof 60

Showing results (551-560 of 591) with videos related to

Sort By:
Pageof 60
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 24, 2020
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysisLaurence Klotz, Giovanni Lughezzani, Davide Maffei, et al.
The Prostate|November 20, 2019
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 studyDaniel P Petrylak, Nicholas J Vogelzang, Kamal Chatta, et al.
The Journal of Urology|June 10, 2026
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and ToxicityArvin George, Eric Giesler, Brian Mazzarella, et al.
Future Oncology (London, England)|November 11, 2025
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, et al.
Urologic Oncology|January 16, 2025
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancerSiamak Daneshmand, Ashish M Kamat, Neal D Shore, et al.
Urologic Oncology|September 21, 2023
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancerNeal D Shore, Dmitry M Polikarpov, Christopher M Pieczonka, et al.
Prostate Cancer and Prostatic Diseases|September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patientsNeal D Shore, Christopher M Pieczonka, Sean Heron, et al.
Urology Practice|August 4, 2023
Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. StudyClaus G Roehrborn, Steven N Gange, Neal D Shore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamideD E Rathkopf, M R Smith, C J Ryan, et al.
Cancer|September 5, 2019
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancerCelestia S Higano, Andrew J Armstrong, A Oliver Sartor, et al.
Pageof 60